An official website of the United States government
NIH Guide: Weekly Index for June 24, 2022
Weekly NIH Funding Opportunities and Notices
June 24, 2022
General Notices
-
Request for Proposals (RFP) Notice: Blueprint MedTech (BPMT) Biocompatibility, Sterilization, and Animal Studies
(NOT-DA-22-062)National Institute on Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
Update: iEdison to Transition from NIH eRA to NIST; Downtime and Action Items Required in Preparation for August 9 Launch of New iEdison
(NOT-OD-22-158)National Institutes of Health
-
Request for Proposals (RFP) Notice: Research and Development for Clinical Studies in the Blueprint MedTech (BPMT)
(NOT-DA-22-063)National Institute on Drug AbuseNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Behavioral and Social Sciences Research
Notice of Changes to Funding Opportunities
-
Notice to Extend Expiration Date for PAR-20-276: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
(NOT-CA-22-092)National Cancer InstituteNational Institute of Dental and Craniofacial Research
-
Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Eligibility
(NOT-TR-22-032)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish Funding Opportunity Announcements for Resource Centers for Minority Aging Research (RCMARs) and AD/ADRD RCMARs (P30 Clinical Trial Optional)
(NOT-AG-22-023)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity Announcement for Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
(NOT-AG-22-024)National Institute on Aging
Notices of Special Interest
-
Notice of Special Interest: Temporal Bone Histological Tissue Scanning Equipment Supplement
(NOT-DC-22-009)National Institute on Deafness and Other Communication Disorders
-
Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs
(NOT-NS-23-001)National Institute of Neurological Disorders and StrokeNational Institute on Aging
-
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity
(NOT-OD-22-135)Office of Nutrition ResearchNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchJohn E. Fogarty International CenterOffice of Research on Women's HealthOffice of Dietary SupplementsOffice of Behavioral and Social Sciences ResearchOffice of AIDS ResearchOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
-
Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements
(NOT-TW-22-003)John E. Fogarty International CenterNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Library of MedicineNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchNational Institute on Minority Health and Health Disparities
Funding Opportunities
-
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
(PAR-22-173)National Cancer InstituteApplication Receipt Date(s): November 4, 2024
-
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
(PAR-22-174)National Cancer InstituteApplication Receipt Date(s): November 4, 2024
-
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
(PAS-22-196)National Institute on AgingNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): September 5, 2025
-
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(PAS-22-197)National Institute on AgingNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): September 5, 2025
-
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
(RFA-AG-23-033)National Institute on AgingApplication Receipt Date(s): October 21, 2022
-
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
(RFA-DA-23-017)National Institute on Drug AbuseApplication Receipt Date(s): November 18, 2022
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 17, 2025
For technical issues E-mail OER Webmaster